Khamis Tomusange

Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-<i>N</i>-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation

Solomon Tadesse, Mingfeng Yu, Laychiluh Mekonnen et al. · Journal of Medicinal Chemistry · 2017 · 68 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +13

Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques

Denise C. Hsu, Piyanate Sunyakumthorn, Matthew D. Wegner et al. · Journal of Virology · 2018 · 40 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Anti-HIV IgM protects against mucosal SHIV transmission

Siqi Gong, Khamis Tomusange, Viraj Kulkarni et al. · AIDS · 2018 · 29 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Discovery and pharmacological characterization of a novel series of highly selective inhibitors of cyclin‐dependent kinases 4 and 6 as anticancer agents

Solomon Tadesse, Laychiluh Bantie, Khamis Tomusange et al. · British Journal of Pharmacology · 2017 · 26 citations · Full text

Medicine, Oncology, Pharmacology +14

A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice

Khamis Tomusange, Danushka K. Wijesundara, Jason Gummow et al. · Scientific Reports · 2016 · 22 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17